Therefore, this study tests the hypothesis whether inflammatory markers, such as high sensitivity CRP (hsCRP), WBC count and ferritin are associated with renal outcome (renal function decline and progression to dialysis) in stages 3–5 CKD patients. The gene discussed is CRP; the disease is chronic kidney disease.